Bile and Pepsin - their Role in GERDHUNGIN, A. P. S; HEADING, R. C.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 2, issn 0953-0673, 39 p.Serial Issue

Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsiaHUNGIN, A. P. S; HILL, C; RAGHUNATH, A et al.Alimentary pharmacology & therapeutics. 2009, Vol 30, Num 4, pp 331-342, issn 0269-2813, 12 p.Article

gastro-oesophageal reflux disease : the health economic implicationsMASON, J; HUNGIN, A. P. S.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 20-31, issn 0953-0673, 12 p.Article

Co-prescription of H2 receptor blockers and proton pump inhibitors with warfarin in general practiceHUNGIN, A. P. S; RUBIN, G. P; O'FLANAGAN, H et al.Postgraduate medical journal. 1999, Vol 75, Num 890, pp 721-722, issn 0032-5473Article

Review article : the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux diseaseTACK, J.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 2, pp 10-16, issn 0953-0673, 7 p.Article

Symptoms in patients on long-term proton pump inhibitors : prevalence and predictorsRAGHUNATH, A. S; HUNGIN, A. P. S; MASON, J et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 4, pp 431-439, issn 0269-2813, 9 p.Article

Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcomePANTER, S. J; O'FLANAGAN, H; BRAMBLE, M. G et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 9, pp 981-988, issn 0269-2813, 8 p.Article

Quality of life in patients with established inflammatory bowel disease: a UK general practice surveyRUBIN, G. P; HUNGIN, A. P. S; CHINN, D. J et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 5, pp 529-535, issn 0269-2813, 7 p.Article

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjectsHUNGIN, A. P. S; WHORWELL, P. J; TACK, J et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 5, pp 643-650, issn 0269-2813, 8 p.Article

Helicobacterpylorieradication in long-term proton pump inhibitor users is highly cost-effective : economic analysis of the HELPUP trialMASON, J. M; RAGHUNATH, A. S; HUNGIN, A. P. S et al.Alimentary pharmacology & therapeutics. 2008, Vol 28, Num 11-12, pp 1297-1303, issn 0269-2813, 7 p.Article

Review article : complete gastro-oesophageal reflux monitoring - combined pH and impedanceTUTUIAN, R; CASTELL, D. O.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 2, pp 27-37, issn 0953-0673, 11 p.Article

How valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?VAKIL, N.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 64-69, issn 0953-0673, 6 p.Article

Extraoesophageal manifestations of gastro-oesophageal reflux diseaseRICHTER, J. E.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 70-80, issn 0953-0673, 11 p.Article

The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitisRAGHUNATH, A. S; HUNGIN, A. P. S; WOOFF, D et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 7, pp 733-744, issn 0269-2813, 12 p.Article

Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general populationKENNEDY, T. M; JONES, R. H; HUNGIN, A. P. S et al.Gut. 1998, Vol 43, Num 6, pp 770-774, issn 0017-5749Article

Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care : a randomized-controlled trialRAGHUNATH, A. S; HUNGIN, A. P. S; MASON, J et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 5, pp 585-592, issn 0269-2813, 8 p.Article

Irritable bowel syndrome in the United States : prevalence, symptom patterns and impactHUNGIN, A. P. S; CHANG, L; LOCKE, G. R et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 11, pp 1365-1375, issn 0269-2813, 11 p.Article

Managing acute renal colic across the primary-secondary care interface: A pathway of care based on evidence and consensusWRIGHT, P. J; ENGLISH, P. J; HUNGIN, A. P. S et al.BMJ. British medical journal (International ed.). 2002, Vol 325, Num 7377, pp 1408-1412, issn 0959-8146, 5 p.Article

Review article : the nature of oesophageal injury in gastro-oesophageal reflux diseaseDE HERTOGH, G; ECTORS, N; VAN EYKEN, P et al.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 2, pp 17-26, issn 0953-0673, 10 p.Article

Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care - A Rome Foundation Working Team ReportHUNGIN, A. P. S; MOLLOY-BLAND, M; CLAES, R et al.Alimentary pharmacology & therapeutics. 2014, Vol 40, Num 10, pp 1133-1145, issn 0269-2813, 13 p.Article

Current concepts in the management of Helicobacter pylori infection: The Maastricht 2-2000 Consensus ReportMALFERTHEINER, P; MEGRAUD, F; O'MORAIN, C et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 2, pp 167-180, issn 0269-2813, 14 p.Article

The long-term use of proton-pump inhibitorsRAGHUNATH, A. S; O'MORAIN, C; MCLOUGHLIN, R. C et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 55-63, issn 0953-0673, 9 p.Article

What do we mean by GERD? : definition and diagnosisJONES, R; GALMICHE, J. P.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 2-10, issn 0953-0673, 9 p.Article

Helicobacter pylori and gastro-oesophageal reflux diseaseDELANEY, B; MCCOLL, K.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 32-40, issn 0953-0673, 9 p.Article

Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional surveyRUBIN, G; HUNGIN, A. P. S; CHINN, D et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 11, pp 1889-1893, issn 0269-2813, 5 p.Article